Mohsen Malekinejad, MD, MPH, DrPH

Title(s)Associate Professor, Epidemiology & Biostatistics
SchoolSchool of Medicine
Address550 16th Street
San Francisco CA 94158
Phone415-644-5146
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPostdoctoral Studies2009HIV prevention
    University of California, BerkeleyDrPH2008Public Health
    University of California, DavisMPH2003Public Health
    Tehran Azad University MD1999General Medicine

    Collapse Overview 
    Collapse Overview
    Mohsen Malekinejad MD, MPH, Dr.PH is an Assistant Professor in the Department of Epidemiology and Biostatistics, the Philip R. Lee Institute for Health Policy Studies (IHPS), and the Institute for Global Health Sciences (IGHS), and the director of the Global Reduce Adverse Childhood Experiences (GRACE) Initiative at UCSF.

    Dr. Malekinejad is medical epidemiologist with expertise in systematic review and meta-analysis, sampling methods for hard-to-reach populations and disease surveillance, with substantive foci in HIV/AIDS, substance use, and most recently childhood adversities. He has also published on TB, sexually transmitted diseases, hepatitis, and other areas of public health addressing health disparities among underserved populations such as persons who inject drugs, non-US-born populations, men who have sex with men, and incarcerated populations. He has worked extensively as part of economic modeling teams.

    Dr. Malekinejad is experienced in leading large research teams domestically and internationally. He has been the PI of several smaller projects and project director of several large multi-site NIH or CDC-funded projects Over the past seven years, he has collaborated with other UCSF investigators as co-investigator and project director on a variety of grants, all expanding his technical expertise and leadership skills (1) Consortium to Assess Prevention Economics (CAPE) (CDC: 2014-2019) in which he led over 15 systematic review projects, (2) Global Health Decisions (GHD) (NIH-funded: 2010 – 2013). In GHD, Dr. Malekinejad led a team that developed a HIV disease burden reduction and cost-effectiveness model for combinations of prevention and treatment strategies via a graphically user-friendly web interface. (3) Global Health Intervention Review (GHIR) (Kaiser Family Foundation-funded: 2009 – 2010). In GHIR Dr. Malekinejad conducted syntheses of systematic reviews on the evidence of efficacy of interventions for eight globally important diseases including HIV/AIDS, TB, and Malaria, incorporating strength of evidence assessments into final review products.

    Dr. Malekinejad has also led multiple collaborative international projects studying the intersection of substance use and blood-borne infections, including an NIH-funded project to study risk factors of transitioning to injection among opioid users. He served as the President of the Scientific Association for Public health in Iran (SAPHIR, 2017-2019), and currently is the co-chair of the Diversity, Equality, and Inclusion at the IGHS. Dr. Malekinejad teaches a systematic review course at UCSF.
    Collapse Global Health Equity

    Collapse Research 
    Collapse Research Activities and Funding
    Development of a reference web-based database for substance use disorders in Iran
    Iranian National Institute of Medical Research and Development 940043Apr 1, 2016 - Mar 30, 2018
    Role: Co-PI
    Description: This project intend to compile data about substance use related indictors in Iran I am the o-PI of this project and will take the lead on the implementation of the project including defining indicators, assist with development of tools and protocol, supervise data synthesis, and contribute to manuscript submission.
    ECONOMIC ANALYSIS FOR PREVENTION OF DISEASE
    US Center for Disease Control and Prevention # 5U38PS004649Sep 30, 2015 - Sep 30, 2019
    Role: Co-investigator, project lead
    Description: This cooperative agreement supports economic analysis for and with CDC for prevention of HIV, hepatitis, TB, and STIs. To conduct analysis of existing data on recruitment strategies for screening of HIV,HCV, HBV, and TB among homeless people and injecting drug users
    Crucial Transitions among Young Opioid Users in Iran
    NIH R21DA029473Sep 15, 2010 - Aug 31, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Collaboration Interests

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Digital exposure notification tools: A global landscape analysis. PLOS Digit Health. 2023 Sep; 2(9):e0000287. Nebeker C, Kareem D, Yong A, Kunowski R, Malekinejad M, Aronoff-Spencer E. PMID: 37656671; PMCID: PMC10473497.
      View in: PubMed   Mentions:
    2. Exposure notification system activity as a leading indicator for SARS-COV-2 caseload forecasting. PLoS One. 2023; 18(8):e0287368. Aronoff-Spencer E, Mazrouee S, Graham R, Handcock MS, Nguyen K, Nebeker C, Malekinejad M, Longhurst CA. PMID: 37594936; PMCID: PMC10437830.
      View in: PubMed   Mentions:
    3. Identification of the socio-cultural barriers of drug addiction treatment in Iran. Heliyon. 2023 May; 9(5):e15566. Razaghi E, Farhoudian A, Pilevari A, Noroozi A, Hooshyari Z, Radfar R, Malekinejad M. PMID: 37131427; PMCID: PMC10149210.
      View in: PubMed   Mentions: 1  
    4. Interventions to enhance psychological resilience in forcibly displaced children: a systematic review. BMJ Glob Health. 2023 02; 8(2). Thabet A, Ghandi S, Barker EK, Rutherford G, Malekinejad M. PMID: 36731918; PMCID: PMC9896216.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Defining Key Performance Indicators for the California COVID-19 Exposure Notification System (CA Notify). Public Health Rep. 2022 Nov-Dec; 137(2_suppl):67S-75S. Aronoff-Spencer E, Nebeker C, Wenzel AT, Nguyen K, Kunowski R, Zhu M, Adamos G, Goyal R, Mazrouee S, Reyes A, May N, Howard H, Longhurst CA, Malekinejad M. PMID: 36314660; PMCID: PMC9678789.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    6. Barriers and Facilitators to Substance Use Disorder Treatment: An Overview of Systematic Reviews. Subst Abuse. 2022; 16:11782218221118462. Farhoudian A, Razaghi E, Hooshyari Z, Noroozi A, Pilevari A, Mokri A, Mohammadi MR, Malekinejad M. PMID: 36062252; PMCID: PMC9434658.
      View in: PubMed   Mentions:
    7. Viral blood-borne infections testing and linkage to care cascade among persons who experience homelessness in the United States: a systematic review and meta-analysis. BMC Public Health. 2022 07 26; 22(1):1421. Saha R, Miller AP, Parriott A, Horvath H, Kahn JG, Malekinejad M. PMID: 35883158; PMCID: PMC9327172.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Indirect COVID-19 health effects and potential mitigating interventions: Cost-effectiveness framework. PLoS One. 2022; 17(7):e0271523. Maya S, Kahn JG, Lin TK, Jacobs LM, Schmidt LA, Burrough WB, Ghasemzadeh R, Mousli L, Allan M, Donovan M, Barker E, Horvath H, Spetz J, Brindis CD, Malekinejad M. PMID: 35849613; PMCID: PMC9292069.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    9. Sexual Practice Changes Post-HIV Diagnosis Among Men Who Have Sex with Men in the United States: A Systematic Review and Meta-analysis. AIDS Behav. 2022 Jul 12. Malekinejad M, Jimsheleishvili S, Barker EK, Hutchinson AB, Shrestha RK, Volberding P, Kahn JG. PMID: 35829969.
      View in: PubMed   Mentions:    Fields:    
    10. Risk of Human Immunodeficiency Virus Acquisition Among High-Risk Heterosexuals With Nonviral Sexually Transmitted Infections: A Systematic Review and Meta-Analysis. Sex Transm Dis. 2022 06 01; 49(6):383-397. Barker EK, Malekinejad M, Merai R, Lyles CM, Sipe TA, DeLuca JB, Ridpath AD, Gift TL, Tailor A, Kahn JG. PMID: 35034049; PMCID: PMC9133024.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    11. Risk of HIV Acquisition Among Men Who Have Sex With Men Infected With Bacterial Sexually Transmitted Infections: A Systematic Review and Meta-Analysis. Sex Transm Dis. 2021 10 01; 48(10):e138-e148. Malekinejad M, Barker EK, Merai R, Lyles CM, Bernstein KT, Sipe TA, DeLuca JB, Ridpath AD, Gift TL, Tailor A, Kahn JG. PMID: 33783414; PMCID: PMC8485981.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    12. The yield of tuberculosis contact investigation in low- and middle-income settings: a systematic review and meta-analysis. BMC Infect Dis. 2021 Sep 27; 21(1):1011. Velleca M, Malekinejad M, Miller C, Abascal Miguel L, Reeves H, Hopewell P, Fair E. PMID: 34579667; PMCID: PMC8474777.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    13. Clarification Regarding "Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses: A Systematic Review". J Infect Dis. 2021 09 01; 224(5):925-926. Razani N, Malekinejad M, Rutherford GW. PMID: 34086941; PMCID: PMC8195204.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    14. Hepatitis B prevalence association with sexually transmitted infections: a systematic review and meta-analysis. Sex Health. 2021 07; 18(3):269-279. Marseille E, Harris AM, Horvath H, Parriott A, Malekinejad M, Nelson NP, Van Handel M, Kahn JG. PMID: 34183114; PMCID: PMC8457403.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Policy Mapping Analysis of Adverse Childhood Experiences Prevention Policies in California. Pediatrics. 2021 Mar 1; 147(3_MeetingAbstract):76-78. Thakur TA, Malekinejad MM. .
      View in: Publisher Site   Mentions:
    16. Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses: A Systematic Review. J Infect Dis. 2021 02 24; 223(4):550-561. Bulfone TC, Malekinejad M, Rutherford GW, Razani N. PMID: 33249484; PMCID: PMC7798940.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCellsPHPublic Health
    17. Change in Condom Use in Populations Newly Aware of HIV Diagnosis in the United States and Canada: A Systematic Review and Meta-Analysis. AIDS Behav. 2021 Jun; 25(6):1839-1855. Malekinejad M, Blodgett J, Horvath H, Parriott A, Hutchinson AB, Shrestha RK, McCabe D, Volberding P, Kahn JG. PMID: 33389321; PMCID: PMC9239206.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review. PLoS One. 2019; 14(9):e0223077. Miller AP, Malekinejad M, Horváth H, Blodgett JC, Kahn JG, Marks SM. PMID: 31568507; PMCID: PMC6768470.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    19. The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders. Health Res Policy Syst. 2018 Aug 16; 16(1):81. Malekinejad M, Horvath H, Snyder H, Brindis CD. PMID: 30115085; PMCID: PMC6097290.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    20. Yield of testing and treatment for tuberculosis among foreign-born persons during contact investigations in the United States: A semi-systematic review. PLoS One. 2018; 13(7):e0200485. Parriott A, Malekinejad M, Miller AP, Horvath H, Marks SM, Kahn JG. PMID: 30024909; PMCID: PMC6053151.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    21. Effectiveness of School-Based Teen Pregnancy Prevention Programs in the USA: a Systematic Review and Meta-Analysis. Prev Sci. 2018 05; 19(4):468-489. Marseille E, Mirzazadeh A, Biggs MA, P Miller A, Horvath H, Lightfoot M, Malekinejad M, Kahn JG. PMID: 29374797.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    22. Care Cascade for targeted tuberculosis testing and linkage to Care in Homeless Populations in the United States: a meta-analysis. BMC Public Health. 2018 04 12; 18(1):485. Parriott A, Malekinejad M, Miller AP, Marks SM, Horvath H, Kahn JG. PMID: 29650047; PMCID: PMC5897923.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    23. Factors Influencing Transition to Shisheh (Methamphetamine) among Young People Who Use Drugs in Tehran: A Qualitative Study. J Psychoactive Drugs. 2018 Jul-Aug; 50(3):214-223. Noroozi A, Malekinejad M, Rahimi-Movaghar A. PMID: 29377788.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    24. Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review. PLoS One. 2017; 12(8):e0180707. Malekinejad M, Parriott A, Viitanen AP, Horvath H, Marks SM, Kahn JG. PMID: 28786991; PMCID: PMC5546677.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    25. Effectiveness of community-based condom distribution interventions to prevent HIV in the United States: A systematic review and meta-analysis. PLoS One. 2017; 12(8):e0180718. Malekinejad M, Parriott A, Blodgett JC, Horvath H, Shrestha RK, Hutchinson AB, Volberding P, Kahn JG. PMID: 28771484; PMCID: PMC5542551.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    26. Transition to and Away from Injecting Drug Use among Young Drug Users in Tehran, Iran: A Qualitative Study. Iranian Journal of Psychiatry and Behavioral Sciences. 2016 Dec 28; 11(1). Rahimi-Movaghar RA, Noroozi NA, Page PK, Mohraz MM, McFarland MW, Malekafzali MH, Malekinejad MM. .
      View in: Publisher Site   Mentions:
    27. Transition to and Away from Injecting Drug Use among Young Drug Users in Tehran, Iran: A Qualitative Study. Iranian Journal of Psychiatry and Behavioral Sciences. 2016 Dec 28; In Press(In Press). Rahimi-Movaghar RA, Noroozi NA, Page PK, Mohraz MM, McFarland MW, Malekafzali MH, Malekinejad MM. .
      View in: Publisher Site   Mentions:
    28. Effectiveness of Policies on Reducing Exposure to Ionizing Radiation From Medical Imaging: A Systematic Review. J Am Coll Radiol. 2015 Dec; 12(12 Pt B):1434-45. Thaker A, Navadeh S, Gonzales H, Malekinejad M. PMID: 26499166.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    29. High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012). Int J Infect Dis. 2015 Nov; 40:116-30. Malekinejad M, Navadeh S, Lotfizadeh A, Rahimi-Movaghar A, Amin-Esmaeili M, Noroozi A. PMID: 26460088; PMCID: PMC8741151.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    30. Transition to injecting drug use in Iran: A systematic review of qualitative and quantitative evidence. Int J Drug Policy. 2015 Sep; 26(9):808-19. Rahimi-Movaghar A, Amin-Esmaeili M, Shadloo B, Noroozi A, Malekinejad M. PMID: 26210009; PMCID: PMC4625838.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    31. High HIV prevalence in a respondent-driven sampling survey of injection drug users in Tehran, Iran. AIDS Behav. 2015 Mar; 19(3):440-9. Malekinejad M, Mohraz M, Razani N, Akbari G, McFarland W, Khairandish P, Malekafzali H, Gouya MM, Zarghami A, Rutherford GW. PMID: 25280446.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    32. Relative risk reduction is useful metric to standardize effect size for public heath interventions for translational research. J Clin Epidemiol. 2015 Mar; 68(3):317-23. Mirzazadeh A, Malekinejad M, Kahn JG. PMID: 25726522; PMCID: PMC5935495.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    33. Visualizing the effect of needle exchange program scale-up in the Russian Federation: Findings from our web-based modeling tool. Annals of Global Health. 2014 Sep 25; 80(3):216-217. Goodell GA, Malekinejad MM, Mirzazadeh MA, Harris HB, Marseille ME, Kahn KJ. .
      View in: Publisher Site   Mentions:
    34. Factors influencing the external validity of the evidence of HIV counseling and testing data in global health settings. Annals of Global Health. 2014 Sep 25; 80(3):188-189. Marseilli ME, Mirzazadeh MA, Malekinejad MM, Kahn KJ, Goodell GA. .
      View in: Publisher Site   Mentions:
    35. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran. Int J Drug Policy. 2014 Jul; 25(4):717-23. Rahnama R, Mohraz M, Mirzazadeh A, Rutherford G, McFarland W, Akbari G, Malekinejad M. PMID: 24974367; PMCID: PMC4231781.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    36. Transition to injection amongst opioid users in Iran: implications for harm reduction. Int J Drug Policy. 2012 Jul; 23(4):333-7. Malekinejad M, Vazirian M. PMID: 21996166.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    37. Accessing a diverse sample of injection drug users in San Francisco through respondent-driven sampling. Drug Alcohol Depend. 2011 Nov 01; 118(2-3):83-91. Malekinejad M, McFarland W, Vaudrey J, Raymond HF. PMID: 21435803.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    38. Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. J Urban Health. 2010 Sep; 87(5):839-50. Kral AH, Malekinejad M, Vaudrey J, Martinez AN, Lorvick J, McFarland W, Raymond HF. PMID: 20582573; PMCID: PMC2937131.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    39. Implementation Challenges to Using Respondent-Driven Sampling Methodology for HIV Biological and Behavioral Surveillance: Field Experiences in International Settings. AIDS and Behavior. 2009 Apr 1; 13(2):385-385. Johnston JL, Malekinejad MM, Kendall KC, Iuppa II, Rutherford RG. .
      View in: Publisher Site   Mentions:
    40. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008 Jul; 12(4 Suppl):S105-30. Malekinejad M, Johnston LG, Kendall C, Kerr LR, Rifkin MR, Rutherford GW. PMID: 18561018.
      View in: PubMed   Mentions: 183     Fields:    Translation:HumansPHPublic Health
    41. Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: field experiences in international settings. AIDS Behav. 2008 Jul; 12(4 Suppl):S131-41. Johnston LG, Malekinejad M, Kendall C, Iuppa IM, Rutherford GW. PMID: 18535901.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansPHPublic Health
    42. Injection drug use in Rural Iran: integrating HIV prevention into iran's rural primary health care system. AIDS Behav. 2008 Jul; 12(4 Suppl):S7-12. Mojtahedzadeh V, Razani N, Malekinejad M, Vazirian M, Shoaee S, Saberi Zafarghandi MB, Hernandez AL, Mandel JS. PMID: 18521737.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    43. HIV risk behavior among injection drug users in Tehran, Iran. Addiction. 2007 Sep; 102(9):1472-82. Razani N, Mohraz M, Kheirandish P, Malekinejad M, Malekafzali H, Mokri A, McFarland W, Rutherford G. PMID: 17645427.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Offer Student Projects

    Run Clinical Trials

    Work in Global Health Equity

    See more options in the Advanced Search tab

    Mohsen's Networks
    Concepts (143)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (23)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-2-gbbe5f151 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.